Back to top

Myriad Genetics: (NASD: MYGN)

(U.S: NASD) As of Apr 16, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$38.33 USD

-0.42 (-1.08%)

Volume: 1,751,475

Zacks Rank : 1-Strong Buy [?] 1        

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Balance Sheet

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

6/30/2013 6/30/2012 6/30/2011 6/30/2010 6/30/2009
Assets          
Cash & Equivalents 372 341 346 403 317
Receivables 98 63 51 48 45
Notes Receivable 0 0 0 0 0
Inventories 5 12 6 0 0
Other Current Assets 9 7 15 23 4
Total Current Assets 484 422 418 474 366
Net Property & Equipment 28 24 23 23 23
Investments & Advances 159 114 71 85 75
Other Non-Current Assets 22 19 0 0 0
Deferred Charges 29 31 26 9 0
Intangibles 70 73 73 0 0
Deposits & Other Assets 13 8 0 2 2
Total Assets 804 691 611 594 466
Liabilities & Shareholders Equity 6/30/2013 6/30/2012 6/30/2011 6/30/2010 6/30/2009
Notes Payable 0 0 0 0 0
Accounts Payable 18 10 11 9 14
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 44 33 22 19 18
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2 2 1 0 0
Total Current Liabilities 65 45 34 27 32
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 11 10 10 9 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 75 55 44 36 32
Shareholders Equity 6/30/2013 6/30/2012 6/30/2011 6/30/2010 6/30/2009
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 697 648 604 567 550
Retained Earnings 31 -13 -39 -10 -120
Other Equity -0 -0 0 0 3
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 729 636 567 558 434
Total Liabilities & Shareholder's Equity 804 691 611 594 466
Total Common Equity 729 636 567 558 434
Shares Outstanding 79.60 84.80 85.70 97.70 95.80
Book Value Per Share 9.15 7.50 6.61 5.71 4.53

Fiscal Year End for MYRIAD GENETICS falls in the month of June.

All items in Millions except Per Share data.

3/31/2014 12/31/2013 9/30/2013 6/30/2013 3/31/2013
Assets          
Cash & Equivalents NA 354 357 372 336
Receivables NA 88 88 98 95
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 5 7
Other Current Assets NA 13 14 9 9
Total Current Assets NA 455 459 484 448
Net Property & Equipment NA 31 31 28 27
Investments & Advances NA 135 159 159 126
Other Non-Current Assets NA 23 22 22 21
Deferred Charges NA 30 28 29 29
Intangibles NA 70 70 70 70
Deposits & Other Assets NA 13 13 13 8
Total Assets NA 757 782 804 729
Liabilities & Shareholders Equity 3/31/2014 12/31/2013 9/30/2013 6/30/2013 3/31/2013
Notes Payable NA 0 0 0 0
Accounts Payable NA 18 19 18 12
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 46 59 44 38
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 4 1 2 3
Total Current Liabilities NA 67 79 65 54
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 12 11 10
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 81 91 75 64
Shareholders Equity 3/31/2014 12/31/2013 9/30/2013 6/30/2013 3/31/2013
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 663 675 697 663
Retained Earnings NA 12 14 31 2
Other Equity NA 1 0 -0 -0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 676 690 729 665
Total Liabilities & Shareholder's Equity NA 757 782 804 729
Total Common Equity 0 676 690 729 665
Shares Outstanding 72.90 74.70 80.40 79.60 80.50
Book Value Per Share 0.00 9.05 8.59 9.15 8.26